BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays - BÜHLMANN Laboratories AG announces a worldwide collaboration with Beckman Coulter for the distribution of fCAL® turbo and fPELA® turbo assays. This partnership enables seamless integration of fecal inflammation and digestion marker testing into automated laboratory workflows.
BÜHLMANN Education Workshop at IFCC WorldLab 2024 - Learn about the calprotectin marker and explore different perspectives : the research lab, clinical value and assay end user experience.
BÜHLMANN Laboratories AG acquired by KLAR Partners to support the continued growth of the Company! - BÜHLMANN Laboratories AG (“BÜHLMANN”) announces the closing of the acquisition by funds advised by KLAR Partners Limited (“KLAR Partners” or “KLAR”) today June 5th, 2024. The acquisition enables BÜHLMANN to support its future as a leading independent specialty in-vitro diagnostics company.

DGKL – DKLM 2024

Date: 26 – 27 September 2024
Location: Bremen, Germany

Deutscher Kongress für Laboratoriumsmedizin 2024. Visit our booth #051.

Deutscher Allergiekongress 2024

Date: 26 – 28 September 2024
Location: Dresden, Germany

19. Deutscher Allergiekongress. Visit our booth #43.

SGPath / ÖGPath

Date: 26 – 28 September 2024
Location: Feldkirch, Austria

Joint Annual Meeting of SGPath and ÖGPath 2024

Séminaire CNBBMM

Date: 26 – 28 September 2024
Location: Toulouse, France

Séminaire de rentrée du Collège national de Biochimie-Biologie moléculaire médicale 2024